Macrogenics (MGNX) Misses Q1 EPS by 20c

Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($0.84), $0.20 worse than the analyst estimate of ($0.64). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $14.86 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'